As of May 24
| +0.83 / +1.18%|
The 22 analysts offering 12-month price forecasts for Bristol-Myers Squibb have a median target of 75.50, with a high estimate of 100.00 and a low estimate of 48.00. The median estimate represents a +5.99% increase from the last price of 71.23.
The current consensus among 26 polled investment analysts is to Buy stock in Bristol-Myers Squibb. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.